Amdocs - DOX Stock Forecast, Price & News

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Amdocs in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DOX shares.
View DOX analyst ratings or view top-rated stocks.

4 Wall Street research analysts have issued twelve-month target prices for Amdocs' stock. Their DOX share price forecasts range from $96.00 to $100.00. On average, they anticipate the company's share price to reach $98.75 in the next twelve months. This suggests a possible upside of 6.1% from the stock's current price.
View analysts price targets for DOX or view top-rated stocks among Wall Street analysts.

Amdocs' stock was trading at $90.90 at the start of the year. Since then, DOX shares have increased by 2.4% and is now trading at $93.08.
View the best growth stocks for 2023 here.

Amdocs saw a drop in short interest in February. As of February 28th, there was short interest totaling 1,090,000 shares, a drop of 10.7% from the February 13th total of 1,220,000 shares. Based on an average trading volume of 631,800 shares, the days-to-cover ratio is presently 1.7 days. Currently, 0.9% of the shares of the company are short sold.
View Amdocs' Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 10th 2023.
View our DOX earnings forecast.

Amdocs Limited (NASDAQ:DOX) posted its quarterly earnings data on Tuesday, November, 2nd. The technology company reported $1.16 EPS for the quarter, missing the consensus estimate of $1.18 by $0.02. The technology company earned $1.09 billion during the quarter, compared to analysts' expectations of $1.11 billion. Amdocs had a trailing twelve-month return on equity of 17.38% and a net margin of 11.71%. During the same quarter in the previous year, the firm posted $1.17 earnings per share.

Amdocs declared a quarterly dividend on Tuesday, January 31st. Stockholders of record on Friday, March 31st will be given a dividend of $0.435 per share on Friday, April 28th. This represents a $1.74 annualized dividend and a dividend yield of 1.87%. The ex-dividend date of this dividend is Thursday, March 30th. This is a positive change from the stock's previous quarterly dividend of $0.40.
Read our dividend analysis for DOX.

ETFs with the largest weight of Amdocs (NASDAQ:DOX) stock in their portfolio include BlueStar Israel Technology ETF (ITEQ), VanEck Israel ETF (ISRA), AAM Bahl & Gaynor Small/Mid Cap Income Growth ETF (SMIG), Formidable Fortress ETF (KONG), American Century Low Volatility ETF (LVOL), ALPS O'Shares U.S. Small-Cap Quality Dividend ETF (OUSM), Ballast Small/Mid Cap ETF (MGMT) and Global X Adaptive US Factor ETF (AUSF).

Amdocs (NASDAQ:DOX) pays an annual dividend of $1.58 per share and currently has a dividend yield of 1.69%. The company has been increasing its dividend for 10 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 35.59%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, DOX will have a dividend payout ratio of 26.55% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for DOX.

Amdocs issued an update on its second quarter 2023 earnings guidance on Tuesday, January, 31st. The company provided earnings per share (EPS) guidance of $1.44-$1.50 for the period, compared to the consensus estimate of $1.32. The company issued revenue guidance of $1.20 billion-$1.24 billion, compared to the consensus revenue estimate of $1.10 billion.

2,315 employees have rated Amdocs Chief Executive Officer Shuky Sheffer on Glassdoor.com. Shuky Sheffer has an approval rating of 90% among the company's employees. 83.0% of employees surveyed would recommend working at Amdocs to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other Amdocs investors own include Home Depot (HD), Pfizer (PFE), AT&T (T), NVIDIA (NVDA), Exxon Mobil (XOM), AbbVie (ABBV), International Business Machines (IBM), Johnson & Johnson (JNJ), Advanced Micro Devices (AMD) and Comcast (CMCSA).

Amdocs trades on the NASDAQ under the ticker symbol "DOX."

Amdocs' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Allspring Global Investments Holdings LLC (4.23%), Pzena Investment Management LLC (4.19%), LSV Asset Management (2.81%), Clal Insurance Enterprises Holdings Ltd (1.90%), Nordea Investment Management AB (1.84%) and Dimensional Fund Advisors LP (1.60%).

Shares of DOX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of DOX stock can currently be purchased for approximately $93.08.

Amdocs (NASDAQ:DOX) has a market capitalization of $11.25 billion and generates $4.58 billion in revenue each year. The technology company earns $549.50 million in net income (profit) each year or $4.44 on an earnings per share basis.

The company employs 30,288 workers across the globe.

Amdocs' mailing address is 1390 Timberlake Manor Parkway, Chesterfield MO, 63017. The official website for the company is www.amdocs.com. The technology company can be reached via phone at (314) 212-7000, via email at dox_info@amdocs.com, or via fax at 1 314 212 7500.